Monitoring helps manage these effects and improve adherence
The randomized evidence establishes continued 2.4 mg treatment versus withdrawal, not a specific lower-dose maintenance band. The 0.5 and 1.0 mg doses have direct efficacy and safety data when assigned as treatment, and small uncontrolled series support testing lower-dose or reduced-frequency maintenance in practice
Kusminski CM, McTernan PG, Kumar S (2005) Role of resistin in obesity, insulin resistance and type II diabetes
Premature resumption of semaglutide after gastrointestinal surgery could potentially affect healing or contribute to gastrointestinal symptoms during recovery
Benoit, S
In Lafayette, Louisiana, Klinic offers a convenient way to explore innovative weight management solutions, such as tirzepatide, also known as Zepbound